Xcout Intel
Scarlet Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Scarlet Therapeutics among biotech companies — ranked by similarity to what Scarlet Therapeutics actually does, not by market-cap band.
Subscribe to see Scarlet Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Scarlet Therapeutics
Scarlet Therapeutics, founded in 2021 and headquartered in Bristol, United Kingdom, is developing a pioneering platform that generates novel red blood cell-based therapeutics to treat a wide range of diseases.
Scarlet Therapeutics at a glance
Scarlet Therapeutics is a biotech company headquartered in United Kingdom. Its most recent funding round, Seed, raised $4.4M in May 2026. Xcout tracks 3 named people at Scarlet Therapeutics, including Alistair Irvine (CEO).
Scarlet Therapeutics leadership
- Alistair IrvineCEO
- Ash ToyeProfessor
- Jan FrayneProfessor
Scarlet Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $4.4M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Scarlet Therapeutics competitors
Ranked by semantic similarity — how close each company is to Scarlet Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Ferrosa Therapeutics AG is a Swiss biotechnology company founded in Basel, Switzerland, focusing on developing novel therapeutics to treat anemia and related conditions.
Biotechnology
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Biotechnology
Carmine Therapeutics, Inc. is an EVX Ventures company headquartered in Cambridge, Massachusetts, focused on developing novel gene therapies.
Similar biotech company
Modus Therapeutics AB is a Swedish clinical-stage biotechnology company developing sevuparin, a proprietary polysaccharide drug candidate with anti-adhesive and anti-inflammatory properties. Its work has focused on treatments for severe inflammatory and vascular conditions, including sickle cell disease, serving patients with serious unmet medical needs.
Biotechnology
Argonaute RNA is a therapeutics company headquartered in Bristol, United Kingdom, pursuing opportunities in RNA-based treatments.
Biotechnology
Skylark Bio is a biotechnology company developing precision-targeted, locally delivered gene therapies to treat genetic hearing loss and other single-gene disorders. The company's platform aims to restore natural biological processes and hearing function, addressing conditions that affect children and individuals with genetic communication impairments.
Biotechnology
Luminary Therapeutics, Inc. is a pre-clinical stage cell therapy development company located in Minneapolis, Minnesota, focused on creating non-viral cell therapies.
Biotechnology
Resolution Therapeutics is a biotechnology research company headquartered in Edinburgh, Scotland. The company is pioneering regenerative macrophage therapies to transform outcomes for people with inflammatory and fibrotic diseases.
Biotechnology
BlueRock Therapeutics is a clinical-stage cell therapy company headquartered in Cambridge, Massachusetts, focused on developing engineered cellular medicines for degenerative conditions.
Biotechnology
Bit Bio is a UK biotechnology company that develops technologies for precisely programming human cells, including its opti-ox platform for producing consistent, scalable cell types. It serves biomedical researchers, drug developers, and regenerative-medicine and cell-therapy developers with engineered human cells and related tools.
Biotechnology
Akari Therapeutics, Plc is a clinical-stage biotechnology firm dedicated to advancing novel treatments for autoimmune and inflammatory disorders. The company's primary investigational therapy is nomacopan, an advanced, second-generation complement inhibitor. This drug is engineered to counteract both inflammatory and prothrombotic processes. Nomacopan holds promise for a range of serious conditions, including paroxysmal nocturnal hemoglobinuria (PNH), Guillain-Barré syndrome (GBS), hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), and bullous pemphigoid (BP). Akari's operations are headquartered in London, United Kingdom.
Biotechnology
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Scarlet Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Scarlet Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →